HGH fragment 176-191 - Livewell Pharmaceuticals

Described first by Bornstein in 1976, HGH Fragment 176-191 is a synthetic peptide derived from the C-terminal region of human growth hormone. Although it cannot stimulate IGF-1 or trigger anabolic growth, it may support fat loss by modulating lipolytic enzymes like HSL. Its action is thought to involve protein kinase C signaling. Despite being widely confused with AOD9604, it is a different compound. Not approved for medical use, it is sold for research and popular among physique athletes seeking fat reduction without growth promotion.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about HGH fragment 176-191 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.